Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

NCT07207564 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07207564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07207564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
August 28, 2025
Completion date
June 30, 2030
Enrollment
4,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma